Tag: Paragraph IV certification
Caroline Wagstaff
Jan
8
8
How Paragraph IV Patent Challenges Speed Up Generic Drug Entry
Paragraph IV certification under the Hatch-Waxman Act lets generic drug makers challenge brand-name patents to speed up affordable drug access. Learn how it works, why it succeeds - and why some drugs stay expensive.
Latest Posts
Popular Posts
-
Childhood Obesity Prevention and Family-Based Treatment: What Works Today
-
FDA Sentinel Initiative: How Big Data Detects Drug Safety Issues
-
Pharmacokinetics and Side Effects: How Your Body Processes Drugs
-
How Paragraph IV Patent Challenges Speed Up Generic Drug Entry
-
Delayed Drug Reactions: What Happens Days to Weeks After Taking a Medication